Mesa Laboratories's total inventories for the quarter that ended in Dec. 2023 was $36.0 Mil. Mesa Laboratories's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $34.4 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Mesa Laboratories's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-49.24.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Mesa Laboratories's Days Inventory for the
three
months ended in Dec. 2023 was 156.51.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mesa Laboratories's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mesa Laboratories's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.64.
Mesa Laboratories Total Inventories Historical Data
The historical data trend for Mesa Laboratories's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Mesa Laboratories (NAS:MLAB) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Mesa Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mesa Laboratories's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Mesa Laboratories Total Inventories Related Terms
Thank you for viewing the detailed overview of Mesa Laboratories's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Mesa Laboratories (Mesa Laboratories) Business Description
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MLAB has been successfully added to your 